Possible association of CCDC62 rs12817488 polymorphism and Parkinson’s disease risk in Chinese population: a meta-analysis

Early-onset vs. Late-onset Parkinson’s disease: A Clinical-pathological Study

(2015) Leslie Wayne Ferguson et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

The single nucleotide polymorphism Rs12817488 is associated with Parkinson’s disease in the Chinese population

(2015) Ri-li Yu et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Target Gene Capture Sequencing in Chinese Population of Sporadic Parkinson Disease

(2015) Zhiming Li et al.   MEDICINE

Genetic association of RIT2 rs12456492 polymorphism and Parkinson’s disease susceptibility in Asian populations: a meta-analysis

(2015) Yanjun Lu et al.   Scientific Reports

CCDC62 Variant rs12817488 Is Associated with the Risk of Parkinson's Disease in a Han Chinese Population

(2013) Rong-Rong Liu et al.   EUROPEAN NEUROLOGY

Movement disorders: new insights into disease mechanisms and treatment

(2013) Werner Poewe et al.   LANCET NEUROLOGY

Genetic Association Study betweenSTK39 and CCDC62/HIP1R and Parkinson’s Disease

(2013) Nan-Nan Li et al.   PLoS One

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

(2011)   LANCET

Pathological roles of α-synuclein in neurological disorders

(2011) Kostas Vekrellis et al.   LANCET NEUROLOGY

CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells

(2009) Ming Chen et al.   CARCINOGENESIS

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity

(2008) Shohei Domae et al.   INTERNATIONAL JOURNAL OF CANCER